相关实验视频
Updated: Jan 7, 2026

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
21.2K
从遗传因果关系到可用药物的目标:一个多组学框架识别了ZSCAN16在痛风病原体中的作用
Chuanliang Chen1, Xifan Zheng1, Zeming Li1
1Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Science progress
|December 10, 2025
概括
这项研究确定ZSCAN16是痛风的有希望的治疗标,一种常见的炎症性关节炎. ZSCAN16显示出与痛风爆发的遗传联系,并且可以服用药物,而TRIM10有安全问题.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 痛风是一种常见的炎症性关节炎,治疗反应不佳.
- 缺乏基因验证的标阻碍了药物开发,并增加了临床试验的磨损.
研究的目的:
- 使用遗传和功能基因组学方法,系统地识别和优先考虑新型,可药物治疗的痛风点.
- 为了验证痛风治疗的安全性和有效性的潜在目标.
主要方法:
- 两个样本的孟德尔随机化 (MR) 与cis表达定量特征位置 (cis-eQTL) 和全基因组关联研究 (GWAS) 数据.
- 贝叶斯定位,全现象关联研究 (PheWAS),单细胞RNA测序 (scRNA-seq) 和用于目标验证的分子对接.
- 评估遗传关联,类型,细胞环境和结构性药物可用性.
主要成果:
- 核磁共振检测发现了15个与痛风有因果关系的基因.
- 优先考虑ZSCAN16作为一种风险增加的目标,特别针对痛风,而TRIM10是保护性的,但显示出显著的质性.
- 在爆发期间,scRNA-seq揭示了细胞毒性T/NK细胞中ZSCAN16的上调;分子对接证实了ZSCAN16的药用性.
结论:
- ZSCAN16是一种高潜力,可药物治疗的痛风治疗标,在急性发作期间与免疫细胞活性有关.
- TRIM10被取消优先权,因为它具有类的负债和不良的化学处理能力.
- 对于未来的痛风药物发现工作,ZSCAN16代表了一个有前途的领先者.
相关概念视频
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Single Nucleotide Polymorphisms-SNPs
17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Genomics
39.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.5K
Genetic Screens
5.5K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.5K
The JAK-STAT Signaling Pathway
11.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.7K

